£495.00

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

2023-2028 Liver Cirrhosis Drugs Outlook Japan - Market Analysis

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 37 days · 37 data points (no recent data)

Historical
Generating forecast…
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 23 August 2026 01 September 2026 10 September 2026 19 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 54 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 37 days • 1 price levels

Days at Price
37 days 0 9 19 28 37 £495 Days at Price

Price Analysis

Most common price: £495 (37 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 37 days

Description

This comprehensive market research study examines the latent demand outlook for liver cirrhosis drugs across Japan's prefectures and cities through 2028. The report provides potential industry earnings (P.I.E.) estimates in millions of U.S. dollars across over 1,000 Japanese cities, enabling precise geographical market analysis. Each city's market share is calculated relative to its prefecture and Japan as a whole, allowing quick comparative benchmarking between regions. The statistical approach directly supports distribution planning and sales force strategy development. Econometric models project fundamental market trends to help pharmaceutical companies, distributors, and healthcare professionals understand regional demand patterns and identify growth opportunities in Japan's liver cirrhosis treatment market.

Key Features

Covers latent demand estimates for liver cirrhosis drugs across over 1,000 cities in Japan from 2023 to 2028.

Provides potential industry earnings (P.I.E.) figures in millions of U.S. dollars for precise market sizing by location.

Includes city-level market share percentages relative to each prefecture and to Japan as a whole for comparative analysis.

Uses econometric models to project fundamental demand trends and support strategic planning for distribution and sales forces.

Published by ICON Group International, Inc., offering established market research methodology and credible industry analysis.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
28 November 2022
Listed Since
08 December 2022

Similar Products You Might Like

The 2023-2028 Outlook for Liver Cirrhosis Drugs in the United States
96% match

The 2023-2028 Outlook for Liver Cirrhosis Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Hepatitis Drugs in the United States
92% match

The 2023-2028 Outlook for Hepatitis Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Hepatitis Therapeutics in the United States
91% match

The 2023-2028 Outlook for Hepatitis Therapeutics in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Genital Herpes Treatments in Japan
91% match

The 2023-2028 Outlook for Genital Herpes Treatments in Japan

£495.00 24 Oct 2026
2023-2028 Monoclonal Antibodies Outlook for Japan - mAbs Market
90% match

2023-2028 Monoclonal Antibodies Outlook for Japan - mAbs Market

£495.00 28 Sep 2026
2023-2028 Bronchitis Treatment Outlook for Japan
90% match

2023-2028 Bronchitis Treatment Outlook for Japan

£495.00 28 Sep 2026
2023-2028 Cognitive Memory Enhancer Drugs Outlook Japan
90% match

2023-2028 Cognitive Memory Enhancer Drugs Outlook Japan

£495.00 28 Sep 2026
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States
90% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States
89% match

The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs for US Zip Codes
89% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs for US Zip Codes

£490.00 27 Sep 2026
2023-2028 Anti-Viral Nucleotide Polymerase Inhibitor Drugs Outlook China
89% match

2023-2028 Anti-Viral Nucleotide Polymerase Inhibitor Drugs Outlook China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Orphan Biologic Drugs in India
89% match

The 2023-2028 Outlook for Orphan Biologic Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes
89% match

The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Allergic Rhinitis in Japan
88% match

The 2023-2028 Outlook for Allergic Rhinitis in Japan

£495.00 15 Sep 2026
2023-2028 Oral Contraceptive Pills Outlook Japan - Market Report
88% match

2023-2028 Oral Contraceptive Pills Outlook Japan - Market Report

£495.00 28 Sep 2026
2023-2028 Oral Iron Therapy Outlook - Japan Market Analysis
88% match

2023-2028 Oral Iron Therapy Outlook - Japan Market Analysis

£495.00 28 Sep 2026
2023-2028 Artificial Tears Market Outlook Japan - Cities & Prefectures
88% match

2023-2028 Artificial Tears Market Outlook Japan - Cities & Prefectures

£495.00 28 Sep 2026
2023-2028 Actinic Keratosis Treatment Outlook Japan
88% match

2023-2028 Actinic Keratosis Treatment Outlook Japan

£495.00 28 Sep 2026
The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in India
88% match

The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in the United States
88% match

The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in the United States

£520.00 27 Sep 2026
2023-2028 Topical Atrophic Scar Treatment Outlook Japan
88% match

2023-2028 Topical Atrophic Scar Treatment Outlook Japan

£495.00 28 Sep 2026
The 2023-2028 Outlook for Antifungal Drugs in India
88% match

The 2023-2028 Outlook for Antifungal Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Cystic Fibrosis Therapeutics for US Zip Codes
88% match

The 2023-2028 Outlook for Cystic Fibrosis Therapeutics for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States
88% match

The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States

£520.00 27 Sep 2026